Neural circuitry underlying the central hypertensive action of nesfatin-1: melanocortins, corticotropin-releasing hormone, and oxytocin

Biostatistical Analysis

Baltosser, W. H., & Zar, J. H. (1996) · Ecology · doi:10.2307/2265725 · Cited by 35,166 · see citing works

The rat brain in stereotaxic coordinates

Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959 · see citing works

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works

Biostatistical Analysis (2nd ed.).

Breen, T. J., & Zar, J. H. (1986) · Journal of the American Statistical Association · doi:10.2307/2289268 · Cited by 5,815 · see citing works

Anatomy and regulation of the central melanocortin system

Cone, R. D. (2005) · Nature Neuroscience · doi:10.1038/nn1455 · Cited by 1,583 · see citing works

Identification of nesfatin-1 as a satiety molecule in the hypothalamus

Oh‐I, S., Shimizu, H., Satoh, T., Okada, S., Adachi, S., Inoue, K., Eguchi, H., Yamamoto, M., Imaki, T., Hashimoto, K., et al. (2006) · Nature · doi:10.1038/nature05162 · Cited by 1,012 · see citing works

Proopiomelanocortin Neurons Are Direct Targets for Leptin in the Hypothalamus

Cheung, C. C., Clifton, D. K., & Steiner, R. A. (1997) · Endocrinology · doi:10.1210/endo.138.10.5570 · Cited by 769 · see citing works

Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004.

Nguyen, N., Magno, C. P., Lane, K., Hinojosa, M., & Lane, J. (2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2008.08.022 · Cited by 638 · see citing works

Evidence That Oxytocin Exerts Anxiolytic Effects via Oxytocin Receptor Expressed in Serotonergic Neurons in Mice

Yoshida, M., Takayanagi, Y., Inoue, K., Kimura, T., Young, L. J., Onaka, T., & Nishimori, K. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5593-08.2009 · Cited by 608 · see citing works

Diet-Induced Obesity Causes Severe but Reversible Leptin Resistance in Arcuate Melanocortin Neurons

Enriori, P. J., Evans, A. E., Sinnayah, P., Jobst, E. E., Tonelli-Lemos, L., Billes, S. K., Glavas, M. M., Grayson, B. E., Perello, M., Nillni, E. A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.02.004 · Cited by 552 · see citing works

Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting.

Sinha, M. K., Opentanova, I., Ohannesian, J. P., Kolaczynski, J. W., Heiman, M. L., Hale, J. E., Becker, G. W., Bowsher, R. R., Stephens, T. W., & Caro, J. F. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118913 · Cited by 531 · see citing works

Identification and Characterization of Nesfatin-1 Immunoreactivity in Endocrine Cell Types of the Rat Gastric Oxyntic Mucosa

Stengel, A., Goebel, M., Yakubov, I., Wang, L., Witcher, D. R., Coşkun, T., Taché, Y., Sachs, G. M., & Lambrecht, N. W. G. (2008) · Endocrinology · doi:10.1210/en.2008-0747 · Cited by 333 · see citing works

Identification of Nesfatin-1 in Human and Murine Adipose Tissue: A Novel Depot-Specific Adipokine with Increased Levels in Obesity

Ramanjaneya, M., Chen, J., Brown, J. E. P., Tripathi, G., Hallschmid, M., Patel, S., Kern, W., Hillhouse, E. W., Lehnert, H., Tan, B. K., et al. (2010) · Endocrinology · doi:10.1210/en.2009-1358 · Cited by 321 · see citing works

Role of Selective Leptin Resistance in Diet-Induced Obesity Hypertension

Rahmouni, K., Morgan, D. A., Morgan, G. M., Mark, A. L., & Haynes, W. G. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2012 · Cited by 319 · see citing works

Peripheral Administration of Nesfatin-1 Reduces Food Intake in Mice: The Leptin-Independent Mechanism

Shimizu, H., Oh-I, S., Hashimoto, K., Nakata, M., Yamamoto, S., Yoshida, N., Eguchi, H., Kato, I., Inoue, K., Satoh, T., et al. (2009) · Endocrinology · doi:10.1210/en.2008-0598 · Cited by 319 · see citing works

Nesfatin-1-Regulated Oxytocinergic Signaling in the Paraventricular Nucleus Causes Anorexia through a Leptin-Independent Melanocortin Pathway

Maejima, Y., Sedbazar, U., Suyama, S., Kohno, D., Onaka, T., Takano, E., Yoshida, N., Koike, M., Uchiyama, Y., Fujiwara, K., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.09.002 · Cited by 317 · see citing works

Comparative Distribution of Vasopressin V1b and Oxytocin Receptor Messenger Ribonucleic Acids in Brain ¹

Vaccari, C., Lolait, S. J., & Ostrowski, N. L. (1998) · Endocrinology · doi:10.1210/endo.139.12.6382 · Cited by 308 · see citing works

Nesfatin-1: Distribution and Interaction with a G Protein-Coupled Receptor in the Rat Brain

Brailoiu, G. C., Dun, S. L., Brailoiu, E., Inan, S., Yang, J., Chang, J. K., & Dun, N. J. (2007) · Endocrinology · doi:10.1210/en.2007-0701 · Cited by 297 · see citing works

Neuroanatomical evidence for reciprocal regulation of the corticotrophin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: Implications for balancing stress and affect

Dabrowska, J., Hazra, R., Ahern, T. H., Guo, J.-D., McDonald, A. J., Mascagni, F., Muller, J. F., Young, L. J., & Rainnie, D. G. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.03.003 · Cited by 274 · see citing works

Central Nesfatin-1 Reduces Dark-Phase Food Intake and Gastric Emptying in Rats: Differential Role of Corticotropin-Releasing Factor2 Receptor

Stengel, A., Goebel, M., Wang, L., Rivier, J., Kobelt, P., Mönnikes, H., Lambrecht, N. W. G., & Taché, Y. (2009) · Endocrinology · doi:10.1210/en.2009-0578 · Cited by 262 · see citing works

Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS

Foo, K. S., Brismar, H., & Broberger, C. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.054 · Cited by 246 · see citing works

Interaction between α-Melanocyte-Stimulating Hormone and Corticotropin-Releasing Hormone in the Regulation of Feeding and Hypothalamo-Pituitary-Adrenal Responses

Lu, X., Barsh, G. S., Akil, H., & Watson, S. J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07863.2003 · Cited by 240 · see citing works

Oxytocin Deficiency Mediates Hyperphagic Obesity of Sim1 Haploinsufficient Mice

Kublaoui, B. M., Gemelli, T., Tolson, K. P., Wang, Y., & Zinn, A. R. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0067 · Cited by 239 · see citing works

Nesfatin-1 crosses the blood–brain barrier without saturation

Pan, W., Hsuchou, H., & Kastin, A. J. (2007) · Peptides · doi:10.1016/j.peptides.2007.09.005 · Cited by 213 · see citing works

Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system

Yosten, G. L. C., & Samson, W. K. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90867.2008 · Cited by 209 · see citing works

α-Melanocyte-Stimulating Hormone Stimulates Oxytocin Release from the Dendrites of Hypothalamic Neurons While Inhibiting Oxytocin Release from Their Terminals in the Neurohypophysis

Sabatier, N., Caquineau, C., Dayanithi, G., Bull, P., Douglas, A. J., Guan, X. M. M., Jiang, M., Van der Ploeg, L., & Leng, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10351.2003 · Cited by 190 · see citing works

The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist

Yosten, G. L. C., & Samson, W. K. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00804.2009 · Cited by 177 · see citing works

Obesity, the sympathetic nervous system, and essential hypertension.

Tuck, M. L. (1992) · Hypertension · doi:10.1161/01.hyp.19.1_suppl.i67 · Cited by 171 · see citing works

Permeability of the blood–brain barrier to a novel satiety molecule nesfatin-1

Price, T. O., Samson, W. K., Niehoff, M. L., & Banks, W. A. (2007) · Peptides · doi:10.1016/j.peptides.2007.10.008 · Cited by 165 · see citing works

Nesfatin-1 increases anxiety- and fear-related behaviors in the rat

Merali, Z., Cayer, C., Kent, P., & Anisman, H. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1252-2 · Cited by 152 · see citing works

Weight loss improves neurovascular and muscle metaboreflex control in obesity

Trombetta, I. C., Batalha, L. T., Rondon, M. U. P. B., Laterza, M. C., Kuniyoshi, F. H. S., Gowdak, M., Barretto, A. C. P., Halpern, A., Villares, S. M., & Negrão, C. E. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01090.2002 · Cited by 150 · see citing works

Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state

Foo, K. S., Brauner, H., Östenson, C., et al. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0254 · Cited by 143 · see citing works

Localization of nesfatin-1 neurons in the mouse brain and functional implication

Goebel‐Stengel, M., Wang, L., Stengel, A., & Taché, Y. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.031 · Cited by 140 · see citing works

PostnatalSim1Deficiency Causes Hyperphagic Obesity and ReducedMc4randOxytocinExpression

Tolson, K. P., Gemelli, T., Gautron, L., Elmquist, J. K., Zinn, A. R., & Kublaoui, B. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5444-09.2010 · Cited by 137 · see citing works

Stressor-responsive central nesfatin-1 activates corticotropin-releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic-pituitary-adrenal axis

Yoshida, N., Maejima, Y., Sedbazar, U., Ando, A., Kurita, H., Boldbaatar, D., Takano, E., Gantulga, D., Iwasaki, Y., Kurashina, T., et al. (2010) · Aging · doi:10.18632/aging.100207 · Cited by 137 · see citing works

Nesfatin-1 inhibits NPY neurons in the arcuate nucleus

Price, C. J., Samson, W. K., & Ferguson, A. V. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.084 · Cited by 115 · see citing works

Increased Plasma Levels of Nesfatin-1 in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Zhang, Z., Li, L., Yang, M., et al. (2011) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0031-1286339 · Cited by 114 · see citing works

Decreased Cerebrospinal Fluid/Plasma Ratio of the Novel Satiety Molecule, Nesfatin-1/NUCB-2, in Obese Humans: Evidence of Nesfatin-1/NUCB-2 Resistance and Implications for Obesity Treatment

Tan, B. K., Hallschmid, M., Kern, W., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1782 · Cited by 111 · see citing works

Leptin and the Cardiovascular System

Rahmouni, K. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.225 · Cited by 110 · see citing works

Brain-Derived Neurotrophic Factor/Tropomyosin-Related Kinase Receptor Type B Signaling Is a Downstream Effector of the Brainstem Melanocortin System in Food Intake Control

Bariohay, B., Roux, J., Tardivel, C., Trouslard, J., Jean, A., & Lebrun, B. (2009) · Endocrinology · doi:10.1210/en.2008-1184 · Cited by 95 · see citing works

Nesfatin-1/NUCB2 may participate in the activation of the hypothalamic–pituitary–adrenal axis in rats

Könczöl, K., Bodnár, I., Zelena, D., Pintér, O., Papp, R. S., Palkovits, M., Nagy, G. M., & Tóth, Z. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.04.012 · Cited by 94 · see citing works

Vasopressin and Oxytocin Neurones of Hypothalamic Supraoptic and Paraventricular Nuclei Co‐Express mRNA for Type‐1 andType‐2 Corticotropin‐Releasing Hormone Receptors

Arima, H., & Aguilera, G. (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00528.x · Cited by 74 · see citing works

Brain oxytocin receptors mediate corticotropin-releasing hormone-induced anorexia

Olson, B. R., Drutarosky, M. D., Stricker, E. M., & Verbalis, J. G. (1991) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1991.260.2.r448 · Cited by 73 · see citing works

Nesfatin-1 stimulates renal sympathetic nerve activity in rats

Tanida, M., & Mori, M. (2011) · Neuroreport · doi:10.1097/wnr.0b013e328346107f · Cited by 67 · see citing works

Control of the erythrocyte free Ca2+ concentration in essential hypertension.

David‐Dufilho, M., Astarie‐Dequeker, C., Pernollet, M.-G., Pino, M. D., Levenson, J. A., Simon, A. C., & Devynck, M. (1992) · Hypertension · doi:10.1161/01.hyp.19.2.167 · Cited by 66 · see citing works

Role of leptin and central nervous system melanocortins in obesity hypertension

da Silva, A. A., Carmo, J. M. D., & Hall, J. E. (2013) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e32835d0c05 · Cited by 63 · see citing works

Nesfatin-1 influences the excitability of neurons in the nucleus of the solitary tract and regulates cardiovascular function

Mimee, A., Smith, P., & Ferguson, A. V. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00266.2011 · Cited by 58 · see citing works

Association between polymorphisms of the Nesfatin gene, NUCB2, and obesity in men

Zegers, D., Beckers, S., Mertens, I. L., Gaal, L. F. V., & Hul, W. V. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.03.007 · Cited by 50 · see citing works

Central Administration of Neuropeptide FF Causes Activation of Oxytocin Paraventricular Hypothalamic Neurones That Project to the Brainstem

Jhamandas, J. H., & MacTavish, D. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.00869.x · Cited by 40 · see citing works

Animal Models in Obesity and Hypertension

Segal‐Lieberman, G., & Rosenthal, T. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0338-3 · Cited by 17 · see citing works

[The sympathetic nervous system and essential hypertension].

Distler, A. (1979) · PubMed · Cited by 8 · see citing works

Obesity, kidney dysfunction and hypertension: mechanistic links

Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0145-4 · Cited by 654 · see citing works

Melanocortins and their receptors and antagonists.

Voisey, J., Carroll, L. J., & van Daal, A. M. (2003) · PubMed · doi:10.2174/1389450033490858 · Cited by 1 · see citing works

Melanocortins and cardiovascular regulation

Versteeg, D. H. G., Van Bergen, P., Adan, R. A. H., & De Wildt, D. J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00615-3 · Cited by 98 · see citing works

The Proopiomelanocortin System

Hadley, M. E., & Haskell‐Luevano, C. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08662.x · Cited by 180 · see citing works

Structure-activity relationships of peptides derived from ACTH, β-LPH and MSH with regard to avoidance behavior in rats

Nispen, J. W. V., & Greven, H. M. (1982) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(82)90032-8 · Cited by 44 · see citing works

Peripheral Effects of Melanocortins

Boston, B. A. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-031-5_5 · Cited by 5 · see citing works